NASDAQ: EVGN
Evogene Ltd Stock Ownership - Who owns Evogene?

Insider buying vs selling

Have Evogene Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EVGN insiders and whales buy or sell their stock.

EVGN Shareholders

What type of owners hold Evogene Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC4.74%316,024$432.95kInstitution
Jane Street Group LLC0.51%33,732$46.21kInstitution
Ubs Group Ag0.28%18,745$25.68kInstitution
Morgan Stanley0.22%14,586$19.98kInstitution
Two Sigma Securities LLC0.20%13,562$18.58kInstitution
Bnp Paribas Financial Markets0.19%12,819$17.56kInstitution
Xtx Topco Ltd0.15%10,179$13.95kInstitution
Steward Partners Investment Advisory LLC0.01%505$691.85Institution
Federation Des Caisses Desjardins Du Quebec0.01%500$685.00Institution
Jpmorgan Chase Co0.00%200$274.00Institution

1 of 2

EVGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EVGN6.31%0.00%
KPRX9.51%90.49%Net Buying
QNRX1.95%7.08%Net Buying
DWTX4.29%64.86%
CANF0.00%0.00%

Evogene Stock Ownership FAQ

Who owns Evogene?

Evogene (NASDAQ: EVGN) is owned by 6.31% institutional shareholders, 0.00% Evogene insiders, and 93.69% retail investors. Armistice Capital LLC is the largest individual Evogene shareholder, owning 316,024.00 shares representing 4.74% of the company. Armistice Capital LLC's Evogene shares are currently valued at $432.95k.

If you're new to stock investing, here's how to buy Evogene stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.